These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6335830)

  • 1. Immunohistochemical evidence against the coexistence of a corticotropin-releasing factor and oxytocin or vasopressin in the rat paraventricular nucleus.
    Taniguchi Y
    Arch Histol Jpn; 1984 Nov; 47(5):475-83. PubMed ID: 6335830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.
    Sawchenko PE; Swanson LW; Vale WW
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1883-7. PubMed ID: 6369332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus.
    Itoi K; Mouri T; Takahashi K; Murakami O; Imai Y; Sasaki S; Yoshinaga K; Sasano N
    Neurosci Lett; 1987 Jan; 73(3):231-6. PubMed ID: 3550528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat.
    Sawchenko PE; Swanson LW; Vale WW
    J Neurosci; 1984 Apr; 4(4):1118-29. PubMed ID: 6609226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis.
    Liposits Z; Paull WK; Sétáló G; Vigh S
    Histochemistry; 1985; 83(1):5-16. PubMed ID: 3900007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    Whitnall MH
    J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of CRF-immunostained cells and magnocellular neurons in the paraventricular nucleus of rat hypothalamus.
    Piekut DT; Joseph SA
    Peptides; 1985; 6(5):873-82. PubMed ID: 3001667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry.
    Walker CD; Tilders FJ; Burlet A
    J Neuroendocrinol; 2001 Jan; 13(1):74-85. PubMed ID: 11123517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existence of CRF and vasopressin immunoreactivity in parvocellular paraventricular neurons of rat hypothalamus.
    Piekut DT; Joseph SA
    Peptides; 1986; 7(5):891-8. PubMed ID: 3540910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunoelectron microscopic localization of corticotropin-releasing factor (CRF-41) and oxytocin in the rat median eminence.
    Dreyfuss F; Burlet A; Tonon MC; Vaudry H
    Neuroendocrinology; 1984 Sep; 39(3):284-7. PubMed ID: 6334245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy.
    Kiss JZ; Mezey E; Skirboll L
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1854-8. PubMed ID: 6608732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus.
    de Goeij DC; Jezova D; Tilders FJ
    Brain Res; 1992 Apr; 577(1):165-8. PubMed ID: 1521142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations.
    Meister B; Villar MJ; Ceccatelli S; Hökfelt T
    Neuroscience; 1990; 37(3):603-33. PubMed ID: 1701038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major pro-vasopressin-expressing and pro-vasopressin-deficient subpopulations of corticotropin-releasing hormone neurons in normal rats. Differential distributions within the paraventricular nucleus.
    Whitnall MH; Gainer H
    Neuroendocrinology; 1988 Feb; 47(2):176-80. PubMed ID: 3257815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
    Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
    J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N; Oliver C; Grino M
    J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of CRF peptide and oxytocin mRNA in the paraventricular nucleus.
    Pretel S; Piekut DT
    Peptides; 1990; 11(3):621-4. PubMed ID: 2381878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus.
    Sawchenko PE
    Brain Res; 1987 Dec; 437(2):253-63. PubMed ID: 3325130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy.
    Kovács K; Kiss JZ; Makara GB
    Neuroendocrinology; 1986; 44(2):229-34. PubMed ID: 3540700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.